REVB

Revelation Biosciences Inc. is a clinical-stage biopharmaceutical company headquartered in New York, focused on developing cutting-edge immunological diagnostics and therapeutics to address significant unmet medical needs in disease prevention and treatment. The company is distinguished by its innovative approach to harnessing the body's immune responses, with a robust pipeline of promising candidates currently advancing through clinical trials. As the healthcare landscape evolves, Revelation Biosciences is positioned to make a meaningful impact in the field of immunology, potentially transforming treatment paradigms and improving patient outcomes.